Psoriasis patients get extended treatment in new safety study

NCT ID NCT07449702

Recruiting now Disease control Sponsor: Oruka Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study continues testing an investigational psoriasis treatment called ORKA-001 to see how safe and effective it is over a longer period. It's for adults with moderate-to-severe plaque psoriasis who already participated in an earlier trial with this medication. Participants will receive treatment for up to 96 weeks followed by 48 weeks of monitoring to track side effects and how well the treatment continues to work.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Oruka Therapeutics Investigative Site
RECRUITING

Los Angeles, California, 90045, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

San Diego, California, 92123, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Santa Ana, California, 92701, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Coral Gables, Florida, 33134, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Bowling Green, Kentucky, 42104, United States

Contact Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Rockville, Maryland, 20850, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

New York, New York, 10023, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Surrey, British Columbia, V3R 6A7, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Markham, Ontario, L3P 1X3, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••
Oruka Therapeutics Investigative Site
RECRUITING

Peterborough, Ontario, K9J 5K2, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PLAQUE PSORIASIS